Litcius/Paper detail

Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis

Mathieu Kernéis, Fleur Cohen, Alain Combes, Zahir Amoura, Carine Paré, Delphine Brugier, Étienne Puymirat, Jérémie Abtan, Benoît Lattuca, Jean‐Guillaume Dillinger, Marie Hauguel‐Moreau, Johanne Silvain, Joe‐Elie Salem, Estelle Gandjbakhch, Guillaume Hékimian, Alban Redheuil, Éric Vicaut, Gilles Montalescot

2023Archives of cardiovascular diseases47 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAnakinraEjection fractionMyocarditisInternal medicineRandomized controlled trialHeart failureClinical endpointPlaceboCardiologyPathologyDiseaseAlternative medicineViral Infections and Immunology ResearchCardiac Fibrosis and RemodelingIL-33, ST2, and ILC Pathways
Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis | Litcius